Literature DB >> 14715713

Differential modulation of energy balance by leptin, ciliary neurotrophic factor, and leukemia inhibitory factor gene delivery: microarray deoxyribonucleic acid-chip analysis of gene expression.

V Prima1, M Tennant, O S Gorbatyuk, N Muzyczka, P J Scarpace, S Zolotukhin.   

Abstract

Most obese animal models, whether associated with genetic, diet-induced, or age-related obesity, display pronounced leptin resistance, rendering leptin supplement therapy ineffective in treating obesity. Ciliary neurotrophic factor (CNTF) has been recently used to invoke leptin-like signaling pathways, thereby circumventing leptin resistance. In the current study, we characterize immediate and long-term molecular events in the hypothalamus of rats exposed to the sustained ectopic expression of leptin, CNTF, or leukemia inhibitory factor, another neurocytokine of IL-6 family, all delivered centrally via a viral vector. The respective transgene-encoded ligands induced similar but not identical metabolic responses as assessed by the reduction in body weight gain and changes in food intake. To define molecular mechanisms of weight-reducing and anorexigenic action of cytokines, we have analyzed the gene expression profiles of 1300 brain-specific genes in the hypothalami of normal rats subjected to the prolonged cytokine action for 10 wk. We present evidence that constitutive expression of cytokines in the brain induces changes in gene expression characteristic of chronic inflammation leading to either temporal weight reduction (CNTF) or severe cachexia (leukemia inhibitory factor). Our results convey a cautionary note regarding potential use of the tested cytokines in therapeutic applications.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14715713     DOI: 10.1210/en.2003-1376

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  14 in total

Review 1.  Hypothalamic mechanisms in cachexia.

Authors:  Aaron J Grossberg; Jarrad M Scarlett; Daniel L Marks
Journal:  Physiol Behav       Date:  2010-03-25

Review 2.  Hypothalamic regulatory pathways and potential obesity treatment targets.

Authors:  Erin E Jobst; Pablo J Enriori; Puspha Sinnayah; Michael A Cowley
Journal:  Endocrine       Date:  2006-02       Impact factor: 3.633

3.  gp130 signaling in proopiomelanocortin neurons mediates the acute anorectic response to centrally applied ciliary neurotrophic factor.

Authors:  Ruth Janoschek; Leona Plum; Linda Koch; Heike Münzberg; Sabrina Diano; Marya Shanabrough; Werner Müller; Tamas L Horvath; Jens C Brüning
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-03       Impact factor: 11.205

4.  Mapping Molecular Datasets Back to the Brain Regions They are Extracted from: Remembering the Native Countries of Hypothalamic Expatriates and Refugees.

Authors:  Arshad M Khan; Alice H Grant; Anais Martinez; Gully A P C Burns; Brendan S Thatcher; Vishwanath T Anekonda; Benjamin W Thompson; Zachary S Roberts; Daniel H Moralejo; James E Blevins
Journal:  Adv Neurobiol       Date:  2018

5.  gp130 receptor ligands as potential therapeutic targets for obesity.

Authors:  Mark A Febbraio
Journal:  J Clin Invest       Date:  2007-04       Impact factor: 14.808

Review 6.  Treatment of human disease by adeno-associated viral gene transfer.

Authors:  Kenneth H Warrington; Roland W Herzog
Journal:  Hum Genet       Date:  2006-04-13       Impact factor: 4.132

7.  A Drug-Tunable Gene Therapy for Broad-Spectrum Protection against Retinal Degeneration.

Authors:  Clayton P Santiago; Casey J Keuthan; Sanford L Boye; Shannon E Boye; Aisha A Imam; John D Ash
Journal:  Mol Ther       Date:  2018-07-19       Impact factor: 11.454

8.  Arcuate nucleus proopiomelanocortin neurons mediate the acute anorectic actions of leukemia inhibitory factor via gp130.

Authors:  Aaron J Grossberg; Jarrad M Scarlett; XinXia Zhu; Darren D Bowe; Ayesha K Batra; Theodore P Braun; Daniel L Marks
Journal:  Endocrinology       Date:  2009-12-16       Impact factor: 4.736

Review 9.  CNTF: a target therapeutic for obesity-related metabolic disease?

Authors:  Vance B Matthews; Mark A Febbraio
Journal:  J Mol Med (Berl)       Date:  2008-01-22       Impact factor: 4.599

10.  CNS-targeted LIF expression improves therapeutic efficacy and limits autoimmune-mediated demyelination in a model of multiple sclerosis.

Authors:  Helena Slaets; Jerome J A Hendriks; Chris Van den Haute; Frea Coun; Veerle Baekelandt; Piet Stinissen; Niels Hellings
Journal:  Mol Ther       Date:  2010-01-12       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.